A woman living with HIV takes an antiretrovirus drug at home in Tajikistan. WHO calls for introducing the first long -acting drug for HIV prevention Healthcare breakthrough in the treatment and prevention of HIV: it is enough to do the injection only twice a year to provide almost complete protection against infection with the virus and the development of AIDS. On Monday, the World Health Organization (WHO) urged to ensure the availability of this drug in pharmacies and clinics. The injection drug Lenkapavir is a highly effective antiretroviral alternative to daily intake of tablets and other, less long-term in action, preventive means, noted in the WHO ~ 60 >~ 60 > “although the HIV vaccine is still inaccessible, Lenkapavir is the best of the available solutions: this is the best of the available solutions: this A prolonged antiretrovirus drug, which, as the studies have shown, prevents almost all cases of infection among people from risk groups, ”said Adkhan Goebreesus CEO. 60 ~ h2 > abbreviations financing ~ 60 > WHO support is of particular importance, given that HIV prevention efforts in the world stalled due to financing problems. To simplify access to the drug, the WHO also recommended to use the express tests for HIV as an alternative to “complex and expensive procedures”. WHO recommendations in relation to Lenkapavir correspond to the position of American healthcare authorities, which approved the drug in June. Access to Lenkapavir outside the clinical tests is still limited. AU called on government, donors and partners to immediately include it in national integrated programs for HIV prevention. Among other supported Prevention measures are daily tablets, injection cabotegravir (introduced once every two months), as well as a vaginal ring with dapivirin. 60 > “is still committed to working with states and partners,” the CHOM emphasized, speaking at the 13th International Conference on a Conference on the 13th International Conference of questions of HIV organized by the International AIDS Society in Kigali, Rwanda. Priority of Prevention and Treatment 62 > 62 >Against the backdrop of large -scale reductions in financing the global efforts to combat HIV/AIDS, including Pepfar’s leading American initiative, the WHO also presented a new guide to maintain priority services in the field of HIV. ~ 60 > ~ ~ ~ ~ p > “We have tools and knowledge in order to put an end to AIDS … Now we need decisive efforts on The introduction of these recommendations based on the principles of justice and focused on the needs of communities, ”said Dr. Meg Dortort, Director of the HU BECAL, sexually transmitted hepatitis and infections. healthcare. According to the end of 2024, 40.8 million people lived with HIV, of which about 65 percent were in Africa, and about 630 thousand people died from the causes associated with the disease. Last year, according to WHO, 1.3 million people became infected, including 120 thousand children. In the group of the highest risk, sex industry workers remain, men who have sexual contacts with men, transgender people, injecting drugs, prisoners, as well as children and adolescents. ~ 60 >~ 60 > there are also positive shifts: access to 2024 Anti-REPUTIONARYS 31.6 million people received compared to 30.3 million a year earlier. Without such treatment, HIV destroys the immune system of the body, which ultimately leads to the development of AIDS. 62 ~